With K-State football finding its new head coach, a school board member drawing months’ worth of public ire with a post and ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the remaining $35 million anticipated to close in Q1 2026.BioAtla ...
Share Market Highlights - Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock ...
Rival railroads claim they’ve found many flaws in the Union Pacific-Norfolk Southern merger application and are asking the Surface Transportation Board to reject the document. The post Competing ...
Escalating interdictions of oil tankers linked to Venezuelan President Nicolás Maduro occur as part of a sweeping naval ...
The case examined GST applicability on large-scale plantation and post-plantation maintenance work by a non-profit entity.
The Act was introduced to tackle project delays, lack of transparency, and misuse of funds, granting homebuyers strong statutory remedies against errant ...
BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...
According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if approved by the FDA, in the fourth quarter of 2026, or earlier under certain circ ...
We now know what Bianca Censori’s BIO POP (THE ORIGIN) is, and furniture does play a key part after all. Thursday (Dec. 11), Censori launched the previously teased project in Seoul, revealing—as had ...
The deadline to file a claim for money from the $177 million AT&T class action settlement is coming up. AT&T agreed to the settlement to resolve a lawsuit that accused it of failing to protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback